logo

In The Spotlight

Share

stocks-aug16.jpg Shares of Checkpoint Therapeutics Inc. (CKPT), a majority controlled subsidiary of Fortress Biotech Inc. (FBIO), are well off their highs recorded last September, and trade around $3.

ipo-aug13.jpg A new week has just begun, and it's that time to take a look at the U.S. biotech IPO calendar of this week.

unum-aug8.jpg It's been a little over 4 months since this clinical-stage biopharmaceutical company debuted on the NASDAQ, and its shares touched a new high yesterday.

zio-aug03.jpg Shares of iRhythm Technologies Inc. (IRTC) touched a new intraday high of $90.40 on Thursday, thanks to investor optimism, boosted by another strong quarter of revenue.

ipo-july16.jpg Although there was no IPO activity in the healthcare sector in the first half of July, there has been a steady stream of new offerings in the second half - with 10 companies making their public debut.

ptch-july23.jpg Shares of PTC Therapeutics Inc. (PTCT) have gained as much as 24% so far this month while the iShares Nasdaq Biotechnology ETF index (IBB) is up just 8.6% for the same period.

ipo-july16.jpg Six biotech companies launched their IPOs in the week ending July 22. Let's take a look at the biotech companies that are going public in the week ahead.

ipo-july16.jpg The IPO activity in the U.S. pharma/biotech sector had a strong showing last quarter (Q2) with 24 listings compared to 13 in the year-ago period. There has not been a single biotech IPO for the month of July so far. But that is about to change.

pharma-daily-071018.jpg Shares of Ra Pharmaceuticals Inc. (RARX) are up nearly 22% so far this month compared to the 8.5% gain of the iShares Nasdaq Biotechnology ETF (IBB) index during the same period.

zafgen-july6.jpg Shares of Zafgen Inc. (ZFGN) are up an impressive 129% year-to-date compared to the 4% gain of the iShares Nasdaq Biotechnology ETF (IBB) index during the same period.

transenterix-june28.jpg Shares of medical device company TransEnterix Inc. (TRXC) are up more than 200% year-to-date.

sangamobuilding-june21.jpg Shares of Sangamo Therapeutics Inc. (SGMO) are down nearly 33% from their 52-week high to $18. Given the fact that the Company has potential clinical data readouts from 7 studies beginning in late summer of this year to 2019, it is worth keeping an eye on this stock.

krystal-june8.jpg Shares of Krystal Biotech Inc. (KRYS) touched a new high of $13.00 on Thursday, and are up 30% since the beginning of this year.

bladdercancer-june1.jpg Shares of Sesen Bio Inc. (SESN) are up more than 37% over the past 3 days while the iShares Nasdaq Biotechnology Index (ETF)(IBB) has gained a mere 1.2% for the same period.

novus-052318.jpg Shares of Novus Therapeutics (NVUS) are up an impressive 47% so far this month while the iShares Nasdaq Biotechnology Index (ETF)(IBB) is up a mere 3% for the same period.

Follow RTT